RxDoctor Payments Data

Kimberly Atwood, PA

Physician Assistant · Durham, NCNPI 1700161593

Payments from drug & device makers

$2,545in general payments, 2019–2025

Across 129 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$319
  • Novartis$268
  • Fresenius USA Marketing, Inc.$235
  • AstraZeneca$196
  • Bayer$187
  • Travere Therapeutics, Inc.$186
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$2,53199%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,545 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$18,468
Medicare patients
102
Services billed
2,416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VelphoroSucroferric Oxyhydroxide24$49,038
AuryxiaFerric Citrate14$29,653
JardianceEmpagliflozin28$19,973
FarxigaDapagliflozin Propanediol15$17,143
Sevelamer Carbonate35$7,625
Torsemide39$1,061
Metoprolol Succinate39$707
Calcitriol30$510
Gabapentin33$470
Lisinopril31$376
Chlorthalidone17$314
Atorvastatin Calcium21$310
Nifedipine ErNifedipine13$297
Losartan Potassium35$291
Furosemide61$287

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Fresenius USA Marketing, Inc.Velphoro$235$49,03824 claims
Akebia Therapeutics IncAuryxia$32$29,65314 claims
Boehringer IngelheimJardiance$35$19,97328 claims
AstraZenecaFarxiga$196$17,14315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →